Browsing by Author "Aguiar, Pedro, Jr."
Now showing 1 - 4 of 4
Results Per Page
Sort Options
- An estimate of the economic impact of immunotherapy relative to PD-L1 expression in Brazil - An update with brazilian costsPublication . Aguiar, Pedro, Jr.; De Mello, Ramon Andrade; Tadokoro, Hakaru; Babiker, Hani; Lopes, GilbertoDelivering high quality cancer care at an affordable cost is one of the main challenges for health care professionals and policy makers, especially in lowand middle-income countries. The objective of our study is to assess the economic impact of nivolumab and pembrolizumab with and without the use of PD-L1 as a biomarker in Brazil.
- Anti-EGFR monoclonal antibodies plus chemotherapy in the first-line treatment of advanced NSCLC: a meta-analysisPublication . Stock, Gustavo; Aguiar, Pedro, Jr.; Santoro, Ilka; Tadokoro, Hakaru; De Mello, Ramon Andrade; Lopes, Gilberto
- Comparative Outcome Assessment of EGFR TKIs for the Treatment of Advanced Non-Small-Cell Lung Cancer: A Network Meta-AnalysisPublication . De Mello, Ramon Andrade; Aguiar, Pedro, Jr.; Cabral, Paloma; Chaves, Fablo; Liu, Davi; Soares, João Paulo; Mountzios, Giannis; Tadokoro, Hakaru; Lopes, Gilberto de Lima
- Estimate of economic impact of immune checkpoint inhibitors for NSCLC relative to PD-L1 expression in the USPublication . Aguiar, Pedro, Jr.; De Mello, Ramon Andrade; Tadokoro, Hakaru; Babiker, Hani; Gutierres, Barbara; Lopes, Gilberto